Clinical Trial Update: Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating abiraterone acetate plus LHRH agonist, and abiraterone acetate plus LHRH agonist with enzalutamide, in prostate cancer; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Enzalutamide (enzalutamide)
• LHRH agonist (Gonadotropin-releasing hormone (GnRH) agonist)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-12-06